Abstract
ObjectivesTo evaluate whether off-patent prescription drugs at risk of sudden price increases or shortages in the United States are available from independent manufacturers approved in other well regulated settings around...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have